Corbus Pharmaceuticals Holdings, Inc.
CRBP
$8.84
-$0.21-2.32%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -95.32% | -74.45% | -65.72% | -48.97% | 9.85% |
| Total Depreciation and Amortization | -60.37% | -47.18% | -30.35% | -15.40% | -8.27% |
| Total Amortization of Deferred Charges | -- | -100.00% | -89.36% | -74.35% | -51.94% |
| Total Other Non-Cash Items | 56.07% | 83.90% | 188.20% | 100.24% | 2.11% |
| Change in Net Operating Assets | 263.56% | 234.27% | -399.45% | -529.79% | -236.20% |
| Cash from Operations | -54.31% | -61.45% | -92.41% | -73.56% | -15.77% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 98.65% | 153.68% | 131.30% | 92.73% | -440.36% |
| Cash from Investing | 98.65% | 153.68% | 131.30% | 92.73% | -440.36% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | -44.75% | -143.13% | -376.75% |
| Issuance of Common Stock | -57.47% | -98.43% | -75.40% | -32.91% | 87,857.00% |
| Repurchase of Common Stock | -- | 82.43% | 91.56% | 91.56% | 91.56% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -53.52% | -98.28% | -81.97% | -42.24% | 6,004.93% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 225.10% | -7.51% | -123.75% | -29.23% | 205.95% |